Investing.com -- Shares of AstraZeneca (ST: AZN) and GlaxoSmithKline (LON: GSK) fell Tuesday after former U.S. President ...

The global preventive healthcare technologies market, valued at $296.48 billion in 2024, is set to hit $1.19 trillion by 2034 ...

Ticks are spreading globally and bringing familiar conditions such as Lyme disease with them, as well as totally new ones.

Dr. Stephana Julia Moss, an investigator at the Canadian Center for Vaccinology (CCfV), Dalhousie University, has been ...

GlaxoSmithKline Pharmaceuticals, with its shares currently priced at Rs 3,292.30, remains a key stock to watch, particularly ...

At ASCO 2025, an expert discusses encouraging new early-phase research in clinical trials on treating myeloma.

The stock of Sigachi Industries tanked 6.88 per cent, Shilpa Medicare dropped 4.92 per cent, Suven Life Sciences declined ...

Early intervention in high-risk smoldering myeloma with lenalidomide delays progression by up to 7 years and achieves ...

Hepatitis B is the most widespread serious liver infection globally, caused by the hepatitis B virus (HBV), which targets and damages the ...

The strong financials and positive sentiment may have contributed to GlaxoSmithKline Pharmaceutical's stock reaching a new 52-week high.

Moderna vaulted to the forefront of biotech, becoming a major pillar of the region’s economy. But Robert F. Kennedy Jr.’s ...

During a live event, Hari Deshpande, MD, and participants discussed the DeFi trial and the management of nirogacestat in ...